Recall Ledger

Ondansetron ODT Tablets recall (Preferred Pharmaceuticals, Inc.)

DrugClass IIOngoing

Summary: Preferred Pharmaceuticals, Inc. is recalling Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01. Reason: Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.

What is being recalled

Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01

Why

Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.

How serious is it

Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.

Where it was sold

Natinowide in the USA

How to tell if yours is affected

Lot: J1325J, I1725P, EXP Date: 4/30/2027.

What to do

Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.

Recall facts

Recall numberD-0239-2026
CategoryDrug
AgencyU.S. Food and Drug Administration (FDA)
SeverityClass II
StatusOngoing
Recall startedNovember 17, 2025
ReportedDecember 24, 2025
CompanyPreferred Pharmaceuticals, Inc.
Company locationAnaheim, CA, United States
Initiated byVoluntary: Firm initiated
Quantity575 1x10 Foil Blister Packs

More recalls from Preferred Pharmaceuticals, Inc. · all drug recalls · recalls from November 2025

Official FDA record